Xinhua Medical Instrument And Guowei Medical Instrument To Set Up Medical Device Firm
This article was originally published in PharmAsia News
Shandong Xinhua Medical Instrument will collaborate with Shandong Guowei Medical Instrument Investment to set up Guangzhou Taimei Medical Devices. Shandong Xinhua will invest RMB 4 million and Shandong Guowei will invest RMB 16 million in the joint venture. The new firm, which will act as an agent for Johnson & Johnson's orthopedics medical devices, will focus on the operation of these devices. (Click here for more - Chinese Language)
You may also be interested in...
The new ALS product is a fixed-dose combo of two ingredients – sodium phenylbutyrate and taurursodiol – that some patients currently are compounding. Amylyx says it will explore ‘all options’ in addressing that, noting its strong IP for Relyvrio, but also committing to access.
Keeping Track: US FDA Clears Santen’s Omlonti, Fennec’s Pedmark; Lilly’s Retevmo Adds Tumor-Agnostic Claim
The latest drug approval news and highlights from the Pink Sheet’s US FDA Performance Tracker
US Interim Funding Bill Gets Biden’s Signature; Window Narrows For Cosmetics, Dietary Supplement Legislation
Passed by the US House and signed into law on 30 September, the Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023, avoids a partial government shutdown and furloughs in FDA user-fee programs. Policy riders stripped from the legislation, including for cosmetics and dietary supplement regulatory changes, could still find their way into a final FY 2023 spending omnibus.